Bayer plans to shift focus away from women’s health drug research
Bayer has announced plans to shift its efforts away from women’s health to focus on diseases, cardiovascular disease, neurology, oncology and immunology.
Bayer agrees to pay $40 million to settle whistleblower claims over 3 prescription drugs
Bayer AG has agreed to pay a $40 million settlement stemming from two whistleblower lawsuits filed in 2005 and 2006 over the company's alleged use of kickbacks and false statements.
Jury sides with Bayer's Monsanto in suit claiming Roundup caused boy's cancer
A Los Angeles jury decided Tuesday that exposure to Monsanto's Roundup weedkiller was not a "substantial factor" in a 10-year-old boy developing cancer.